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Mutations in the ASPM gene at the MCPH5 locus are expected to be the most common cause of human autosomal
recessive primary microcephaly (MCPH), a condition in which there is a failure of normal fetal brain development,
resulting in congenital microcephaly and mental retardation. We have performed the ﬁrst comprehensive mutation
screen of the 10.4-kb ASPM gene, identifying all 19 mutations in a cohort of 23 consanguineous families.Mutations
occurred throughout the ASPM gene and were all predicted to be protein truncating. Phenotypic variation in the
51 affected individuals occurred in the degree of microcephaly (5–11 SDs below normal) and of mental retardation
(mild to severe) but appeared independent of mutation position.
Human autosomal recessive primary microcephaly
(MCPH [MIM 251200]; appendix A) (ﬁg. 1) is a rare
disorder in which the head circumference is reduced be-
cause of a congenital deﬁciency of fetal brain growth,
particularly affecting the cerebral cortex (Bundey 1997;
Mochida and Walsh 2001). The MCPH brain, although
small, is structurally normal, and the phenotypic result
is mental retardation but no other neurological defect
(Aicardi 1998). Genetic heterogeneity has been shown,
with ﬁve loci (MCPH1–5) reported to date (Jackson et
al. 1998, 2002; Jamieson et al. 1999, 2000; Roberts et
al. 1999; Moynihan et al. 2000; Pattison et al. 2000),
all of which are clinically indistinguishable disorders
(Roberts et al. 2002). Linkage analysis has identiﬁed
MCPH5 on chromosome 1q31 (Jamieson et al. 2000;
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Pattison et al. 2000) as potentially the most common
MCPH locus, accounting for 43% (24/56) of MCPH
families in the northern Pakistani population that was
studied (Roberts et al. 2002).
The ASPM gene (abnormal, spindle-like, microceph-
aly-associated [MIM 650481]), the human orthologue
of the Drosophila abnormal, spindle gene (asp) (Ripoll
et al. 1985), was recently identiﬁed as the MCPH5 gene
(Bond et al. 2002). ASPM is composed of 28 exons with
a 10,434-bp ORF (NCBI GenBank accession number
AF509326) and encodes 3,477 amino acids. Collectively,
exon 3 (1,486 bp) and exon 18 (4,755 bp) contain most
of the coding region of the gene. ASPM is predicted to
contain an amino terminal microtubule binding domain
(Saunders et al. 1997), a calponin homology domain,
74 isoleucine-glutamine (IQ) domains (which potentially
bind calmodulin) (Craig and Norbury 1998; Bond et al.
2002), and a carboxy-terminal region with no identiﬁed
domains. The predicted ASPM protein is conserved be-
tween human, mouse, Drosophila, and worm, with a
consistent correlation of nervous-system complexity and
protein length, principally involving an increase in the
number of encoded IQ domains (Bond et al. 2002).Dro-
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Figure 1 A northern Pakistani individual with MCPH. This in-
dividual has the sloping forehead typical of those with MCPH. He
and other affected members of his family have an ASPM mutation
described in this report.
sophila asp is associated with the minus ends of micro-
tubules at spindle poles in mitosis and meiosis (Ripoll
et al. 1985; Gonzalez et al. 1990). Drosophila asp mu-
tants are embryonic lethal, and in the CNS many neuron
progenitors are unable to complete asymmetric cell di-
vision, arresting in metaphase (Gonzalez et al. 1989).
We have previously reported four homozygous ASPM
mutations in four consanguineous northern Pakistani
families linked to the MCPH5 locus (Bond et al. 2002).
We now report our comprehensive mutation analysis of
a further 23 consanguineous families: 17 from northern
Pakistan (a Pakistani individual with MCPH is shown
in ﬁg. 1), 2 white Dutch families (1 of which has been
previously described as part of “family seven” in the
work of Van den Bosch [1959]), 2 families from Yemen,
1 Jordanian Bedouin family, and 1 Saudi Arabian family.
The 23 families encompass a total of 51 affected indi-
viduals, all of whom are homozygous for the MCPH5
region and excluded from linkage to theMCPH1–4 loci.
The study was approved by the Ethical Committee of
the Combined Leeds Health Care Trusts and informed
consent was obtained from all subjects involved or, in
the case of subjects under 18 years of age, from their
parents.
Within our 23 consanguineous families, we identiﬁed
a greater phenotypic spectrum than previously de-
scribed. Of the 23 families studied, 19 displayed head
circumferences of 5–11 SDs below the mean (corrected
for age and sex) and had mild to moderate mental re-
tardation (ﬁg. 2a). The remaining four families (two
northern Pakistani families, each with four affected
members, and two Yemeni families, each with one af-
fected member) all had severe mental retardation and
head circumferences of 10–11 SDs below the mean
(shown as squares in ﬁg. 2a). These individuals were
unable to read or write, displayed primitive language
skills, and could perform only the most basic tasks. No
affected individual had seizures, spasticity, dementia, or
psychiatric disease.
To aid mutation detection, the 17 northern Pakistani
families were initially categorized by genotyping novel
and published microsatellite repeats in a 0.6-Mb re-
gion centered upon the ASPM gene (1pter-D1S2816-
AL139418TG18-AL353809TA20-AL353809GA13-
[ASPM]-AL356315TG19-AL356315CA20-1qter).
Within these 17 families, 11 haplotypes (A–K)were iden-
tiﬁed, of which 1 haplotype was common to 4 families
and 3 haplotypes were each common to 2 families (ap-
pendix B, table B1). The genomic structure of ASPM
had previously been determined, and intronic primers
had been designed to amplify and sequence across the
ASPM coding regions, including splice and polyadeny-
lation sites (Bond et al. 2002). The ASPM gene was
directly sequenced from genomic DNA in one affected
individual from each northern Pakistani haplotype and
from each of the other families.
Different homozygous mutations were identiﬁed in all
11 northern Pakistani haplotypes, as well as the Jor-
danian family, the Saudi Arabian family, and the two
Yemeni families (table 1). Both of the Dutch families
displayed the same mutation. To conﬁrm the segregation
of each mutation, genomic DNA from members of each
family was assessed for the respective alteration. In 20
families, 16 mutations segregated correctly. However,
three of the families from northern Pakistan (two fam-
ilies with haplotype B and one family with haplotype C)
did not exhibit the expected mutations. Upon screening
of an individual from each of these families, three dif-
ferent mutations were identiﬁed, two on the haplotype
B background and one on the haplotype C background.
These mutations segregated with the disease within the
respective families. Therefore, although analysis of ge-
notype data from the six markers ﬂanking ASPM iden-
tiﬁed 11 separate haplotypes, it failed to discriminate
between all mutation-speciﬁc haplotypes. This may be
because of the paucity of polymorphic microsatellite
markers in the ASPM region, but it more likely reﬂects
mutational heterogeneity, even in a seemingly ethnically
and geographically deﬁned population.
In total, 19 homozygous ASPM mutations (ﬁg. 2b) and
12 nonpathogenic SNPs (appendix C, table C1) were
identiﬁed in our 23 families. Of these, 17 mutations
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Figure 2 The position of ASPM mutations identiﬁed in families with MCPH5. a, ASPM mutation position compared to the degree of
microcephaly. On the x axis, the position of the ASPM gene mutations (listed in table C1) is shown, with the gene sequence aligned 5′r3′. The
head circumference of individuals with MCPH5 in whom a mutation was found in this study is shown on the y axis. The head circumference
is shown as a SD from the mean (corrected for age and sex). Some points represent more than one affected individual. Those individuals who
were judged to exhibit severe mental retardation are shown as unﬁlled squares, whereas those with mild or moderate mental retardation are
represented as ﬁlled triangles. There is no relationship between mutation position and head circumference or the degree of mental retardation.
b, The ASPM protein as a schematic with the major protein domains depicted; CH (diagonally striped box) depicts the calponin homology
domain, and the IQ domain repeats (light gray hatched box) are represented. The position of the large nonterminal exons 3 and 18 are indicated
beneath the corresponding region they encode. Novel mutations identiﬁed in this study are shown as ﬁlled arrows. Unﬁlled arrows indicate
mutations reported in the work of Bond et al. (2002). Mutations found in more than one family are denoted with an asterisk.
were novel and 2 mutations, 1258delTCTCAAG and
9159delA, had previously been reported in the northern
Pakistani population (Bond et al. 2002). All mutations
were predicted to cause premature protein truncation. In
nine of the mutations, deletions of one to seven consec-
utive nucleotides resulted in the addition of 4 to 33 amino
acids downstream of the mutation (translations per-
formed using the INFOBIOGEN program), terminating
because of the generation of a stop signal (table 1). Sin-
gle-base changes caused 10 mutations, 7 of which intro-
duced immediate-stop codons. The three remaining point
mutations occurred at splice-donor sites as follows:
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Table 1
Mutations in ASPM Causing Premature Protein Truncation
MUTATION HAPLOTYPE LOCATION ALTERATIONa ASPM SIZEb FAMILIESc POPULATION
349CrT A Exon 2 Immediate stop 116 1 Northern Pakistani
1258delTCTCAAGd B1e Exon 3 Frameshift, ORF incorporating
31 aa then stop
450 2 Northern Pakistani
9190CrT B2e Exon 21 Immediate stop 3,063 1 Northern Pakistani
IVS95GrT (29365GrT) B3e Intron 7 Removes splice-donor site, ad-
ditional 2 aa then stop
981 1 Northern Pakistani
1990CrT C1f Exon 4 Immediate stop 663 1 Northern Pakistani
8508delGA C2f Exon 18 Frameshift, ORF incorporating
33 aa then stop
2,869 1 Northern Pakistani
3082GrA D Exon 11 Removes splice-donor site, ad-
ditional 3 aa then stop
1,030 1 Northern Pakistani
4581delA E Exon 18 Frameshift, ORF incorporating
23 aa then stop
1,550 1 Northern Pakistani
4795CrT F Exon 18 Immediate stop 1,598 1 Northern Pakistani
7895CrT G Exon 18 Frameshift, ORF incorporating
15 aa then stop
2,634 1 Northern Pakistani
9159delAd H Exon 21 Frameshift, ORF incorporating
4 aa then stop
3,056 1 Northern Pakistani
9557CrG I Exon 23 Immediate stop 3,185 2 Northern Pakistani
IVS251GrT (99841GrT) J Intron 25 Removes splice-donor site, ad-
ditional 29 aa then stop
3,357 1 Northern Pakistani
3663delGg K Exon 15 Frameshift, ORF incorporating
12 aa then stop
1,223 2 Northern Pakistani
3811CrT Exon 16 Immediate stop 1,270 2 Dutch
3527CrG Exon 14 Immediate stop 1,175 1 Jordanian
1959delCAAA Exon 4 Frameshift, ORF incorporating
13 aa then stop
666 1 Saudi Arabian
1727delAGg Exon 3 Frameshift, ORF incorporating
32 aa then stop
607 1 Yemeni
9754delAg Exon 24 Frameshift, ORF incorporating
9 aa then stop
3,260 1 Yemeni
a Mechanism of truncation caused by mutation.
b Predicted size in amino acids of the truncated protein product.
c Number of families with mutation.
d Mutations previously reported in other northern Pakistani families (Bond et al. 2002).
e Three mutations were associated with the haplotype B background.
f Two mutations were associated with the haplotype C background.
g Mutations associated with severe mental retardation.
3082GrA, the last base of exon 11, removed the splice-
donor site exon/intron 11, G/gtrA/gt (using the Berkeley
Drosophila Genome Project splice prediction program,
donor-motif probability was reduced from 0.89 to !0.1),
potentially allowing transcription read-through for a fur-
ther three amino acids until an alternative stop signal was
reached (ﬁg. 3a); IVS251GrT (99841GrT), an in-
tronic mutation at exon/intron 25, G/gtrG/tt (donor-mo-
tif probability reduced from 0.76 to !0.1), incorporated
29 amino acids into the protein before a stop signal was
reached (ﬁg. 3b); IVS95GrA (29365GrA) was an
intronic mutation in exon/intron 9, T/gtacgrT/gtaca. The
wild-type sequence (T/gtacg) was predicted to be a poor
splice-donor site, but we had previously sequencedhuman
fetal brain ASPM cDNA (Bond et al. 2002) and had con-
ﬁrmed splicing to occur at nucleotide 2936 ofASPM. The
mutation IVS95GrA reduced the donor-motif proba-
bility from 0.21 to !0.01, allowing the incorporation of
two amino acids into the protein before a stop signal was
reached (ﬁg. 3c).
The mutations identiﬁed in the Dutch, Jordanian,
Saudi Arabian, and Yemeni families were not identiﬁed
in the Pakistani cohort. Three homozygous deletions
(3663delG in two Pakistani families; 1727delAG and
9754delA each in a single Yemeni family) were associ-
ated with MCPH with severe mental retardation. Inter-
estingly, an outlying cousin from a typical Pakistani
family with MCPH (haplotype J) was identiﬁed as a
compound heterozygote by haplotype analysis. In com-
parison to her affected cousins, she had a more profound
degree of mental retardation and was heterozygous for
mutations IVS251GrT (seen in her affected, homo-
zygous cousins) and 3663delG (associated with severe
mental retardation). Her head circumference was 9 SDs
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Figure 3 Mutations in ASPM splice-donor motifs. The splice-donor site (the last guanine of the exon in boldface and the guanine-thymidine
of the intron in plain text) is shown as a broken boxed area drawn onto the wild-type genomic sequence. In each panel, the upper genomic
sequence is wild type, and the lower contains the mutation, indicated by an arrow. Bases that are exonic are shown in boldface, and those that
are potentially translated intronic sequence are shown in italicized boldface. The normal and novel amino acids introduced by the failure to
splice and the translation read-through are indicated beneath the wild-type and mutation sequences, respectively. The predicted premature stop
codons caused by the mutations are indicated as OPA (opal) and OCH (ochre). a, The exon 11 splice-donor site is removed by a GrA mutation
at base 3082, thus allowing the incorporation of an additional three amino acids into the protein before translation termination. b, The point
mutation GrT at IVS251 eliminates the splice-donor site, allowing translation to continue until a stop signal is reached 29 codons downstream.
c, The point mutation GrA at IVS95 is predicted to remove the splice-donor site, therefore translation continues for a further two amino
acids until a translation-termination motif is reached.
below the mean, whereas the head circumference of hap-
lotype J/IVS251GrT was 7 SDs below the mean and
that of haplotype K/3663delG was 11 SDs below the
mean.
We found no evidence for a heterozygote effect of
carrying an ASPM gene mutation; such an effect has
been previously postulated (Qazi and Reed 1975). Par-
ents of the affected individuals in this study had normal
intellect and head circumference. All were proven to be
heterozygotes for the ASPM gene mutation found in
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their affected child, excepting those who had died prior
to our clinical studies and who therefore could not be
tested.
In our individuals with MCPH5, the minimum pre-
dicted ASPM size was 116 aa, resulting from the most
5′ mutation, 349CrT. We had previously reported loss
of the C-terminal 425 amino acids to be the minimum
truncated region to cause MCPH (Bond et al. 2002), but
in this study the mutation IVS251GrT redeﬁned the
minimum common truncated region to be the C-terminal
149 amino acids. The remaining mutations were found
throughout the gene (ﬁg. 3). Despite containing 45% of
the ASPM coding sequence, the AT-rich exon 18 dis-
played a relative paucity of mutations but a high pro-
portion of nonpathogenic SNPs.
We have identiﬁed 19 mutations in the ASPM gene in
families linked to MCPH5, but none of the changes ap-
pear to be common. All of the mutations were predicted
to lead to protein truncation with the resulting protein
ranging in size from 116 aa (349CrT) to 3,357 aa
(IVS251GrT). The severity of the degree of MCPH
and of mental retardation varied considerably within
and between families. There appeared to be no corre-
lation between the phenotype and the size of the pre-
dicted mutant protein. The MCPH5 phenotype could be
due to instability of the truncated ASPM protein, non-
sense-mediated decay (NMD) of the mRNA, or the ab-
sence of an essential but unknown C-terminal protein
domain. As non–protein-truncating pathogenic muta-
tions in ASPM were not observed in the cohort with
MCPH5, it is possible that these will cause a discrete
phenotype. Our study suggests that mutations leading
to premature ASPM protein termination are the major
cause of MCPH, given the prevalence of MCPH5 in the
northern Pakistani population and the detection of mu-
tations in multiple ethnic groups. It seems most likely
that NMD is the mechanism by which mutations in the
ASPM gene cause the reduced fetal brain growth that
results in MCPH.
Notes added in proof.—A sixthMCPH loci (MCPH6)
has recently been reported (Leal et al. 2003). Two further
homozygous mutations have been found in families
linked to MCPH5, 3663delG in a northern Pakistani
family and 1365GrT in a Turkish family (who were
previously described in Jamieson et al. 2000).
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Appendix A
Clinical Deﬁnition of MCPH
The phenotype of MCPH has been deﬁned as congenital microcephaly of at least 4 SDs below the expected mean
for age and sex, with mild/moderate mental retardation but no other neurological, growth, health, or dysmorphic
ﬁndings, and no discernible prenatal or postnatal syndrome or cause, such as an aberrant chromosome or structural
brain anomaly. Seizures are no more frequent than in the general population.
Appendix B
Haplotype Analysis of a 0.6-Mb Region on Chromosome 1q for 17 Northern Pakistani Families with MCPH5
The initial assigned haplotypes are shown, as are the number of families with each haplotype, the polymorphic
microsatellite markers used in the study, and the genotyping results used to determine the haplotypes. The markers
are arranged centr1qter, and novel markers have been described elsewhere (Bond et al. 2002).




























D1S2816 3 1 2 3 3 1 1 1 3 2 1
AL139418TG18 2 3 1 4 2 2 1 3 1 3 2
AL353809TA20 1 4 1 4 3 5 2 4 1 4 5
AL353809GA13 2 1 1 1 2 1 1 1 1 1 1
AL356315TG19 3 3 3 1 2 3 2 4 4 1 4
AL356315CA20 3 3 3 1 2 3 2 4 4 1 3
a n p No. of families with haplotype.
Appendix C
SNPs in ASPM Identiﬁed in 12 Individuals
Of the 12 SNPs identiﬁed, 3 altered an amino acid.
However, in each of these instances, at least one indi-
vidual carrying the homozygous SNP exhibited a stop








2747CrT 9 None 1
3138GrA 12 None 3
3714TrC 15 None 1
4344ArG 18 None 3
4449GrA 18 None 2
5856ArG 18 None 1
5961ArG 18 None 2
7605GrA 18 None 4
7674CrT 18 None 3
7684ArG 18 SerrGly 4
7939CrA 18 LeurIle 8
9395TrG 22 LeurArg 3
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cgi-bin/traduc_in.pl (for translation of nucleotide sequence
to amino acids)
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